Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2003
08/27/2003CN1439004A Indole derivatives useful for treatment of CNS-disorders
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438993A Ethylenediamine derivatives
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438888A 稳定的液体制剂 Stable liquid formulation
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119345C Benzo (5,6) cycloheptapyridine compounds use furl as farnesyl protein transferase inhibitors
08/27/2003CN1119344C Heterocyclic substed, pyrrolidine amide derivatives
08/27/2003CN1119343C Substituted aminocycloalkylpyrrolidine derivatives
08/27/2003CN1119337C Substituted 2,4-diamino-1,3,5-triazine as herbicide
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/26/2003US6610856 Tinuvin P-hindred amine light stabilizer and derivatives thereof
08/26/2003US6610852 Prevent tissue damage; antidiabetic agents; Alzheimer's disease
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610736 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610730 Viricides; protease inbhibitor
08/26/2003US6610723 Imidazole derivatives
08/26/2003US6610717 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610712 Aryloxy piperidinyl derivatives for the treatment of depression
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610707 Heterocyclic compounds as inhibitors of rotomase enzymes
08/26/2003US6610704 Antithrombotic amides
08/26/2003US6610701 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
08/26/2003US6610698 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases
08/26/2003US6610692 Anticoagulants
08/26/2003US6610678 Corticotropin-releasing factor antagonists; treating endocrine, psychiatric or neurologic disorders
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610641 Transition metal complex
08/26/2003US6610518 Using Cytochrome p450
08/26/2003US6610323 An enteric coated pharmaceutical dosage form comprising an H+,K+- ATPase inhibitor is disclosed. The dosage form comprises at least two portions of the H+,K+- ATPase inhibitor to be released in at least two consecutive pulses.
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/26/2003CA2092211C Imidazole compounds, their preparation and use
08/21/2003WO2003069411A1 Visible radiation sensitive composition
08/21/2003WO2003068772A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068767A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068757A1 Novel pyridin- and pyrimidin-derivatives
08/21/2003WO2003068754A1 Therapeutic substituted indazole derivatives
08/21/2003WO2003068753A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors
08/21/2003WO2003068236A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003067987A1 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
08/21/2003WO2003067986A1 Δ1 pyrrolines and the use thereof in pest control
08/21/2003WO2003037890A3 Piperidines
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation
08/21/2003WO2003020217A3 Novel pyrazole analogs acting on cannabinoid receptors
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2003004006A8 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
08/21/2003WO2003001887A3 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
08/21/2003WO2002100847A3 Factor xa inhibitor
08/21/2003WO2002062755A3 Polyamide analogs as dna minor groove binders
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003WO2001097753A3 Novel methods using pyridine derivatives
08/21/2003US20030158424 Substituted alpha, beta-anellated butyrolactones
08/21/2003US20030158418 Novel imidazonline compounds
08/21/2003US20030158417 Indole type compound derivatives for use as antiinflammation or antiproliferative agents, treating cardiovascular disorders, Alzheimer's disease
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158405 N-benzhydryl indole compounds
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158233 Compositions and methods for treating heart failure
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158222 2-3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (an-tipsychotic agents)
08/21/2003US20030158219 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor
08/21/2003US20030158218 Amino-substituted N-(arylalkyl)amidomethyl- pyridine or pyrimidine derivative or its N-oxide
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158216 2-acyl indole derivatives and their use as antitumor agents
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
08/21/2003US20030158198 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/21/2003US20030158179 Quinoline derivatives
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003US20030158173 NK 1 antagonists
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2476024A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1336611A1 Dehalogeno compounds
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1080